Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia

Autor: Johanssen, T, McVeigh, L, Erridge, S, Higgins, G, Straehla, J, Frame, M, Aittokallio, T, Carragher, NO, Ebner, D

Publikováno v: Johanssen, T, Mcveigh, L, Erridge, S, Higgins, G, Straehla, J, Frame, M, Aittokallio, T, Carragher, N O & Ebner, D 2023, ' Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia ', Frontiers in Oncology, vol. 12 . https://doi.org/10.3389/fonc.2022.1075559

Glioblastoma (GBM) remains a cancer of high unmet clinical need. Currentstandard of care for GBM, consisting of maximal surgical resection, followed byionisation radiation (IR) plus concomitant and adjuvant temozolomide (TMZ),provides less than 15-mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80e8f9cd4c4055006f05c987ad669b76
https://www.pure.ed.ac.uk/ws/files/321563058/Glioblastoma_and_the_search_for_non_hypothesis_driven_combination_therapeutics_in_academia_Review.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Combined CDK4 Inhibition and Doxorubicin Restores Smad3 Tumor Suppression and Induces Apoptosis Via a Survivin-Associated Mechanism

Autor: Hamdan, R.^1,2, Tarasewicz, E.^1,2, Nunez, O.^1,2, Straehla, J.^1,2, Hardy, A.^1,2, Zelivianski, S.^1,2, Jeruss, J.^1,2

Publikováno v: Journal of Surgical Research. Feb2013, Vol. 179 Issue 2, p341-341. 1p.